DiscoverLife, Science and MarketingHaydn Boehm: Applying a scientist's curiosity to continuous marketing experimentation and the impact of AI on pharmaceutical R&D
Haydn Boehm: Applying a scientist's curiosity to continuous marketing experimentation and the impact of AI on pharmaceutical R&D

Haydn Boehm: Applying a scientist's curiosity to continuous marketing experimentation and the impact of AI on pharmaceutical R&D

Update: 2024-04-09
Share

Description

Life, Science, and Marketing Podcast: Episode 13

Guest: Haydn Boehm, Product Marketing Excellence Lead at Agilent Technologies

Haydn's Background:

  • PhD in organic chemistry
  • Deep technical expertise combined with marketing roles at various life science companies (Sigma Aldrich, Johnson Matthey, Merck, Thermo Fisher, Agilent, etc.)

Key Discussion Points:

  • Shift from sales-led to marketing-led organizations due to digital transformation
  • Identifying where target audiences go to learn and providing valuable content there
  • Perspectives on lead nurturing, inbound marketing, and the rise of outbound outreach
  • The promise and limitations of AI in drug discovery processes
  • Applying scientific thinking and a problem-solving mindset to marketing strategy

Key Quotes:

  • "You don't wanna employ sales people to act as marketers. They need to speak to people who are engaged and say, right, what are we gonna do now?"
  • "Assume nothing. And validate everything. And so you look at, so it always gives you quite sort of fresh eyes into a sort of a situation."
  • "If people learn to like to learn on their own, it's about putting the right content that's really valuable is a lot rich in terms of education."
Comments 
In Channel
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Haydn Boehm: Applying a scientist's curiosity to continuous marketing experimentation and the impact of AI on pharmaceutical R&D

Haydn Boehm: Applying a scientist's curiosity to continuous marketing experimentation and the impact of AI on pharmaceutical R&D